Ranbaxy Metformin Product Recall (2020-02-26)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
RAN-Metformin 850 mg Tablet
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| AJY8006A, AJY8007A, AJY8005A, AJY8005B, AJY8008A | - Recalling Firm
- Sun Pharma Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
- Marketing Authorization Holder
- Sun Pharma Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
| B. RAN-Metformin 500 mg Tablet | DIN 02269031 | Tablet | Meformin hydrochloride 500 mg |
| AJZ8005A | - Recalling Firm
- Sun Pharma Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
- Marketing Authorization Holder
- Sun Pharma Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
| RAN-Metformin 850 mg Tablet | DIN 02269058 | Tablet | Meformin hydrochloride 850 mg |
-
RAN-Metformin 850 mg Tablet
-
RAN-Metformin 500 mg Tablet
Presence of N-nitrosodimethylamine (NDMA) above or near the interim acceptable concentration limit in affected lot(s).
Wholesalers, Healthcare Establishments, Retailers